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This symposium had two chairmen
because of its wide-ranging concern with
health, covering issues of boron reproduc-
tive toxicity at one extreme and boron
essentiality at the other. Dr. Ernest
Mastromatteo was asked to summarize the
issues presented by the speakers, with a spe-
cial focus on human effects. Dr. Frank
Sullivan was asked to summarize the pre-
sentations with a special focus on implica-
tions for future research.
Summary of Issues
Many ofyou have seen me worriedly writ-
ing in the corner, sometimes furiously, try-
ing to get down all the very important
points that the conference speakers were
making. It is now my task to try to sum up
this conference and to give you my idea of
the implications for human health on the
basis of the latest information presented
here. There was a wide range of papers,
including the chemical and physical prop-
erties of the element and its compounds;
their uses; the various methods for the
analysis of boron in plants, animals, and
humans, as well as in air, water and soil; the
biochemical and pharmacological effects of
boron in plants, animals, and humans; the
effects ofdietary boron in experimental ani-
mals; the effects of boron in human nutri-
tion and human physiology; the toxicology
ofboric acid and borax, including develop-
mental and reproductive toxicity; and the
assessment ofhealth effects among workers
exposed to boric acid and borates in their
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production and use.
We all learned that boron is ubiquitous
in the human environment. Over the
United States, atmospheric concentrations
of boron average about 0.5 ng/m3 of air.
Boron concentrations in the surface waters
of the United States average less than 0.3
mg/I, but can range as high as 15 mg/l in
regions draining boron-rich soils. A survey
of 100 U.S. drinking water supplies
showed a median boron concentration of
0.03 mg/!.
We received information about the
boron content offoods, ranging from a low
of 0.16 pg/g dry weight in red meat to
about 160 ppm in quince. The average
U.S. diet contains 2.5 to 3 pg/g of boron
and provides a dietary intake in humans of
about 1.5 mg boron/day.
The major uses of boron in our society
are in the production ofglass and ceramics,
detergents, bleaches, fire retardants, disin-
fectants, alloys, specialty metals, preserva-
tives, pesticides, and fertilizers. Since it is
so ubiquitous in its distribution and use,
the analysis of trace amounts of boron in
biological and other samples is very impor-
tant. But there are difficulties in sampling
and analytic methods. Current analytic
techniques include colorimetric methods,
inductively coupled plasma atomic emis-
sion spectroscopy (ICP-AES), ICP mass
spectrometry, and neutron activation
analysis. Sample preparation is critical in
much ofthe analytic work. And, ofcourse,
borosilicate glass must never be used as a
sample container.
Too, we know that boron is an essential
micronutrient for plant growth, but its
actual biochemical function is not well
understood in plant biochemistry. Recent
studies have demonstrated that plants may
require boron to stimulate ascorbate
metabolism. These studies are consistent
with the hypothesis that boron overcomes
aluminum toxicity to plants by increasing
ascorbate supply.
Boron's effects in animals is equally
compelling. Drosophila flies under
increased dietary levels of boron experi-
enced a 10% increase in their longevity.
Boron recently has been demonstrated to
overcome the effects ofvitamin D deficien-
cy in chickens and rats. It appears that
boron, in combination with vitamin D3
enhances the mineral content of bone,
while boron alone enhances the maturation
ofgrowth cartilage. Boron is therefore ben-
eficial to bone growth in animals. This was
confirmed in another study in which boron
supplementation to rats' diets, which were
deficient in calcium and magnesium,
produced an increase of serum
calcium and serum magnesium to normal
levels. The addition of dietary boron in
animals increased femoral length, peak load
bearing, and strength, as well as the peak
load bearing and strength of the lumbar
vertebra.
There were important findings reported
from dietary studies in humans as well.
These findings support the hypothesis that
boron may well be essential for humans.
Boron added to the diet ofboron-deprived
women decreased urinary excretion and
plasma concentrations ofcalcium and mag-
nesium; decreased the urinary excretion
and plasma concentration ofphosphorus in
women who were fed a low boron and
magnesium diet; and increased plasma
testosterone and 17-n estradiol. In a subse-
quent human study ofsubjects maintained
for 63 days on a low-boron and low-mag-
nesium diet, supplementation with boron
increased plasma-ionized calcium and
serum 25-hydroxycholecalciferol and
decreased the concentration ofserum calci-
tonin, osteocalcin, and glucose. Urinary
excretion of hydroxyproline indicated col-
lagen turnover, and increased cyclic-AMP
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indicated new bone formation. These stud-
ies suggest that boron has a very important
function in humans that involves
macromineral and cellular metabolism at
the cell membrane level.
Still another study with humans suggests
that boron may have an important role in
human brain function, but further study
on this is needed. Boron given to male ath-
letes in a separate study failed to demon-
strate any effect in strength tests and in
lean muscle mass. Female athletes given
boron showed no effect on mineral density.
Serum calcium and magnesium were
increased and serum phosphorus decreased
in athletes, but I could not be sure whether
this was related to the effects oftraining or
to the boron supplementation. It seemed
that the first factor was far more important.
The symposium then turned its atten-
tion to toxicity of boron and boron
compounds. Boric acid has a low, acute
oral-toxicity ofabout 4,000 mg/kg ofbody
weight in rats. It does not penetrate intact
skin, but readily penetrates broken skin.
The inorganic borates are absorbed readily
following ingestion or inhalation, and are
excreted mainly by the kidneys. Over 95%
of absorbed boron is excreted by the kid-
neys, and its biological half-life is less than
one day.
Further, subchronic feeding studies in
mice and rats have demonstrated reproduc-
tive effects in males through testicular cell
damage and atrophy. The testicular dam-
age showed a threshold effect, and the
threshold in mice seemed to be about
4,500 ppm as boric acid in the diet. There
was no genotoxic effect. Studies have been
made to determine the mode of action of
boron-induced testicular damage in rats. It
does not seem to result from the accumula-
tion of boron in the testis, but may be
caused by boron interference with DNA
and RNA synthesis in germinal cells. The
actual mechanism is not yet elucidated.
A retrospective standardized birth-ratio
study of male workers exposed to sodium
borate dust at levels in the order of 10
mg/m3 of air showed no evidence of any
exposure-related effect on fertility.
Studies of developmental effects of
boron have been carried out in mice, rats,
and rabbits, and have shown that there are
developmental changes. The no-observed-
adverse-effect-level (NOAEL) for boric
acid was found to be equal to or greater
than 125 mg/kg for rabbits and 450
mg/kg for mice. In the rat, a lowest-
observed-adverse-effect-level (LOAEL) of
78 mg/kg resulted in decreased fetal
weight. The developmental abnormalities
noted, however, are found at or near the
level that produce maternal toxicity.
The mammalian NOAEL and LOAEL
for developmental effects appear to me to
afford a wide margin of safety in terms of
human exposure. I would invite your dis-
cussion on this conclusion.
Turning from animal studies to studies
ofman, a report was presented on workers
in the borate-producing industry who were
exposed to sodium-borate dust in mining
and processing. Pulmonary function tests
were done in 1981, and they were followed
up in 1988. The only changes in pul-
monary function were those attributable to
aging and to cigarette smoking. There were
no changes that could be attributed to
exposure to the borate dust among the 303
workers who were tested at both times.
Workers with a borate-dust exposure aver-
aging 5.7 mg/im3 of air complained infre-
quently ofcough and irritation ofthe eyes,
nose, and throat, but more frequently than
those with lesser exposures. Effects were
considered mild and only elicited on
repeated questioning of the worker. Their
exposure level may be compared to the
Occupational Safety and Health
Administration (OSHA/MSHA PEL) of
10 mg/im3 and the CAL-OSHA PEL of 5
mg/m3. Another study involved the bio-
logical monitoring of 14 workers employed
in packing and shipping in a plant where
borax in its three commercial hydration
states was handled. Airborne dust levels of
these sodium borates ranged from 3.3 to
18 mg/m3. Expressed as boron, these were
0.5 to 2.67 mg/im3. Calculated doses,
including dietary intake for the workers at
the high end of the exposure range, aver-
aged 0.38 mg boron/kg ofbodyweight per
day. In my opinion, this affords a large
margin ofsafety over the NOAELs derived
from animal data for impaired testicular
function.
Now, I would like to present my quick
overview of the health implications of
boron. First, a comment on boron as an
essential element for humans is needed. I
think at this conference, we seemed to be
moving nearer to the beliefthat boron may
well be essential to humans. I asked our
colleagues this question: Who makes the
decision that boron is essential in humans?
At present, the last scientific opinion is not
in, so we must keep an open mind on
boron's essentiality for humans.
In terms of the environment, the use of
borates in detergents and the use ofborate
fertilizers and pesticides may result in some
release of boron compounds to the envi-
ronment. Most boron seems to come from
natural sources, because ofsoils and waters
that are rich in boron. At any rate, I did
not learn in this conference ofany environ-
mental health problems from boron expo-
sure at levels present in the general envi-
ronment. There are some local areas with
high boron concentrations in the soil and
natural waters. It might be interesting to
conduct follow up studies on those areas.
We heard repeatedly from one speaker of
different parts of the world where they
have such high levels, and it would be nice
that these be studied in scientific detail.
In terms ofoccupational exposure, there
does not seem to me to be a risk of cancer
or ofsystemic poisoning at the boron levels
that are encountered in our occupational
activities. Similarly, I do not believe that
there is a significant risk of reproductive
effects in males or females, ofdevelopmen-
tal defects in pregnant women, or of aller-
gic disease among workers engaged in the
production and use ofboron compounds.
The epidemiologic study reporting pul-
monary function results and mild irritant
effects does not provide any real evidence
ofadverse effect, although it was limited in
its scope. Nevertheless, an exposure limit or
a guideline of 10 mg/m3 appears applica-
ble to boric acid and the borates.
The health effects ofthe boron fluorides,
the boranes, and organic boron compounds
have not been addressed in the present
symposium and need to be assessed sepa-
rately from those of the sodium borates
and boric acid.
In regard to pharmaceutical use of
boron, I talked briefly about the
organoboron compounds under investiga-
tion for some uses in humans. We still
must await further developments in clinical
trials before we can judge these as effective
therapeutic agents in humans. Inorganic
boron compounds have been recommend-
ed by some for the prevention and treat-
ment of various forms of arthritis and
osteoporosis. Personally, I think we need
further clinical study ofsuch use before we
can be assured ofefficacy.
Implications for
Future Research
I will briefly discuss some of the points
which seem to me, as a relative outsider, to
merit further research. It seems quite clear
that for plants boron is an essential
micronutrient, which at high concentra-
tions becomes phytotoxic. The major ques-
tion to be answered is whether this
nutritive/toxic relationship also applies to
mammals. If in mammals boron is an
essential nutrient, are higher doses likely to
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be toxic? In toxicology there is an old adage
that there's no such thing as a toxic chemi-
cal; there is only a toxic dose. That adage
very much applies to boron.
We have used the term "boron-deficient
diet" quite extensively during the confer-
ence, and that implies that there were par-
ticipants who think that boron is an essen-
tial micronutrient in mammals. But the
question that has not been answered, and
thus one ofthe areas for future research, is
whether there is a clinical condition of
boron deficiency. Several speakers have
reported that when subjects were put on
boron-supplemented diets, they have
shown changes in various parameters.
However, the changes all seemed relatively
small, and I am not very convinced that
this is good evidence that boron is an
essential micronutrient. And of course,
there are ethical problems about working
with normal volunteers, which limits the
studies that can be performed.
Among the conference presentations
were discussions about arthritis, particular-
ly from Dr. Newnham and others. This is
an important area; and if it is true that
boron deficiency leads to inflammatory dis-
ease and other illnesses, then it is crucial
that this should be investigated. Study is
particularly important because most
advances in therapeutics are made by drug
companies; since boron is not a patentable
compound, it is unlikely that any drug
company will spend the money necessary
to develop compounds like borates for pro-
moting health. Boron's nonpatentable sta-
tus poses the problem of how this whole
topic could be studied and developed, and
ifnecessary, findings made available for use
by the public.
These are compelling areas for research,
and I think that some questions that need
to be answered are the following: Is boron
essential, and if so, for what is it essential?
How much boron is required? Participants
here have mentioned needs for 1 mg, 3
mg, or 10 mg ofboron per day; and stud-
ies are required to answer this. Another
important question is, at what level does
boron become harmful? There is an invert-
ed, U-shaped curve where increased doses
bring about beneficial effects, but further
increased doses bring about toxic effects. It
is important to try to establish some para-
meters on this, and it does seem that there
are many natural experiments out there.
We have had discussions about Chile,
Australia, New Zealand, and other coun-
tries where people are exposed either to
very high levels or very low levels ofboron,
and it would be a good research project to
study people living in those regions.
Still another important area for research
is into assay methods. The available meth-
ods are extremely sensitive, but it is not
known how much boron is lost or gained
during extraction of samples. Therefore, it
is not known exactly what the normal
blood-boron level in humans really is.
There is obviously a need for interlaborato-
ry comparisons. Since most of the con-
cerned research experts in the world
attended this conference, why not reunite
to agree on a program for standardization
and quality control ofmethodology for the
sake ofconsistency?
I foresee other needs that arose from this
conference. I was disappointed that in this
meeting we did not really get any indica-
tion ofwhat the chemical species is in the
blood. After discussions about borax,
borates, and boric acid, no one defined
exactly what is measured in the blood. Do
all of these produce the same substance in
blood and tissues?
Another important consideration is the
medicinal use of borates and boron com-
pounds. The paper on carboxyboranes
showed that they have a wide range of
actions. This is not surprising ifthese com-
pounds are acting through prostaglandins
and interleukins, since these would influ-
ence a very wide range of diseases, from
arthritis through allergies and immunolo-
gy. These are such fundamental body sys-
tems, there is no reason these drugs could
not have a very wide range of effects.
However, with a complex ofsubstances like
carboxyboranes, one would need good evi-
dence that boron is a key factor. There has
also been discussion about effects of boron
on calcium metabolism, osteoporosis, and
membrane function. These are all of very
fundamental importance in medicine and
biology, and constitute an area of research
that would well merit investigation.
Still another area ofdiscussion that mer-
its research is agricultural use of boron.
There are clear advantages for agriculture
from improving or increasing boron levels,
and there was an interesting contribution
to the discussion about the large number of
soil samples in the United States that are
boron-deficient. However, as we add more
boron into agriculture, more gets into the
plants, and thus the food chain, which gets
into people. Work on agriculture cannot be
divorced from the work on human medi-
cine and human toxicology, because they
are all closely tied. Research is very impor-
tant to ensure that boron's use in agricul-
ture is not a potential source ofharm.
Finally, I want to comment on the toxi-
cology studies. The reproductive toxicology
falls into two divisions-the effects on fer-
tility and the effects on pregnancy. The
animal studies make clear that at high
doses, these compounds are reproductive
toxins. However, the effects on fertility in
animals are not of concern, because we
have a series ofhuman studies that I think
are unique inasmuch as they have exam-
ined probably the most continuously-
exposed worker population. Workers have
been studied from the perspectives ofexpo-
sure, absorption, blood and urine-boron
levels, fertility, and so on. It does seem
that, in this highly exposed population of
workers, there is no adverse effect on their
fertility as assessed by the number of chil-
dren, or evidence of infertility. These peo-
ple are exposed to sodium borate dust lev-
els ofup to 28 mg/day of boron, and so I
feel that we need not be concerned with
the antifertility effects ofboron.
However, there may be cause for concern
in the developmental toxicity data. It is
extremely difficult to get data on chemical
exposures ofwomen during pregnancy. The
animal data are not excessively worrying,
because there is a reasonably high safety
margin; nevertheless, a researcher is never
very comfortable in this kind ofstudy with-
out having human data. An effort should be
made to identify whether there are popula-
tions ofwomen exposed to borates.
Consider, for instance, that women have
been using borax and perborate in washing
powder for 100 years, and if there were
any important effect there, it is likely it
would have been noticed. However, until
some studies have been carried out, we
cannot be confident that there is no effect
on pregnancy.
Finally, there was mention in the sym-
posium of various populations exposed to
high concentrations of boron in drinking
water. Studies on the fertility and pregnan-
cy outcome in these populations may be
worthwhile, although the difficulties of
conducting such studies should not be
underestimated.
Volume 102, Supplement 7, November 1994 141